Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-05-06 18:40:14
Reporting Period:
Accepted Time:
2020-05-06 18:40:14
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374988 E. Diane Wilfong Gilead Sciences, Inc.
333 Lakeside Drive
Foster City CA 94404
Svp, Controller & Cao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-04 11,486 $66.36 23,685 No 4 M Direct
Common Stock Disposition 2020-05-04 12,264 $80.09 11,421 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2020-05-04 11,486 $0.00 11,486 $66.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,829 2027-02-10 No 4 M Direct
  1. The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
  2. Sale prices reported for the transactions reported here range from $80.07 to $80.14. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.